Application

18313017 · ADJUVANTED VACCINES CONTAINING MODIFIED S1 SPIKE PROTEIN OF SARS-COV-2 VARIANT C.1.2 FOR SUBCUTANEOUS ADMINISTRATION AND METHODS OF USE

Filed 2023-05-05 · Granted · Patent 11911461 (2024-02-27) The official file ↗The patent and its PDF ↗ · Art unit 1648 · Examiner Barry A Chestnut Easy · CPC A61K 39/215 · D4 Labs, LLC · King & Spalding LLP (ATL)

Office actions

first was Notice of allowance

RCEs

no appeal

To first action

5.3 mo

to disposition 9.8 mo

Statutes raised

0 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.